1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Molecular Diagnostics Market Analysis: By Products (Analyzers, Reagents); By Technology (PCR, INAAT, Hybridization, DNA Sequencing and Next Generation Sequencing, Microarray, Spectral Karyotype Imaging (SKI), Others); By End Users (Hospitals, Clinical Lab

Molecular Diagnostics is a diasnosis technique that utilizes DNA, RNA and proteins to detect specific health condition or diseases. Molecular Diagnostics represents enormous market growth of in-vitro diagnostics and now-a-days routinely used in hospitals, reference labs, and blood banks.

This report gives an in-depth segmentation of the market by products, technology and applications. It also segmented by end user verticals and key geographic regions like Americas, Europe and Asia-pacific. Cost analysis, pricing analysis and the overall competitive landscape of key players are also analyzed in great detail in the report.

Competitive landscape for each of the product types is highlighted and market players are profiled with attributes of company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of the key players for 2014 are provided.

The prominent players profiled in this report are:
Abbott Diagnostics
Beckman Coulter
Becton
Dickinson & Co
Biomérieux.
The report contains the most detailed and in-depth segmentation of the global Molecular Diagnostics market.

Table Of Contents

Molecular Diagnostics Market Analysis: By Products (Analyzers, Reagents); By Technology (PCR, INAAT, Hybridization, DNA Sequencing and Next Generation Sequencing, Microarray, Spectral Karyotype Imaging (SKI), Others); By End Users (Hospitals, Clinical Lab
1. Molecular Diagnostics Market - Market Overview

2. Executive Summary

3. Molecular Diagnostics Market - Market Landscape

3.1. Market Share Analysis

3.2. Comparative Analysis

3.2.1. Product Benchmarking

3.2.2. End user profiling

3.2.3. Patent Analysis

3.2.4. Top 5 Financials Analysis

4. Molecular Diagnostics Market - Market Forces

4.1. Market Drivers

4.2. Market Constraints

4.3. Market Challenges

4.4. Attractiveness of the Industry

4.4.1. Power of Suppliers

4.4.2. Power of Customers

4.4.3. Threat of New entrants

4.4.4. Threat of Substitution

4.4.5. Degree of Competition

5. Molecular Diagnostics Market - Government Regulations

6. Molecular Diagnostics Market - Strategic Analysis

6.1. Value Chain Analysis

6.2. Pricing Analysis

6.3. Opportunities Analysis

6.4. Product/Market Life Cycle Analysis

7. Molecular Diagnostics Market - By Products

7.1. Analyzers

7.2. Reagents

8. Molecular Diagnostics Market - By Technology

8.1. PCR

8.2. INAAT

8.3. Hybridization

8.4. DNA Sequencing and Next Generation Sequencing

8.5. Microarray

8.6. Spectral Karyotype Imaging (SKI)

8.7. Others

9. Molecular Diagnostics Market - By End Users

9.1. Hospitals

9.2. Clinical Laboratories

9.3. Academics

10. Molecular Diagnostics Market - By Applications

10.1. Infectious Disease

10.1.1. HBV

10.1.2. HCV

10.1.3. HIV

10.1.4. TB

10.1.5. CT/NG

10.1.6. HPV

10.1.7. MRSA

10.1.8. Others

10.2. Oncology

10.2.1. Prostate Cancer

10.2.2. Breast Cancer

10.2.3. Colorectal Cancer

10.2.4. Others

10.3. Genetic Disease Screening

10.4. Blood Screening

10.5. Microbiology

10.6. Others

11. Molecular Diagnostics Market - Geographic Analysis

11.1. Americas

11.2. Europe

11.3. APAC

11.4. ROW

12. Market Entropy

12.1. New Product Launches

12.2. MandAs, Collaborations, JVs and Partnerships

13. Company Profiles (Overview, Financials, SWOT Analysis - Top 5 Companies, Developments, Product Portfolio)

13.1. Abbott Diagnostics, Inc.

13.2. Beckman Coulter, Inc.

13.3. Becton, Dickinson and Co.

13.4. Biomerieux

13.5. Cepheid, Inc.

13.6. Gen-Probe, Inc. (Hologic, Inc.)

13.7. Novartis AG

13.8. Qiagen N.V.

13.9. F. Hoffmann-La Roche Ltd.

13.10. Siemens Healthcare

13.11. Myriad Genetics, Inc.

13.12. Danaher Corporation

13.13. Bio-Rad Laboratories, Inc.

13.14. Quest Diagnostics, Inc.

13.15. Thermo Fisher Scientific

13.16. Johnson and Johnson

13.17. Sysmex

13.18. Bayer Healthcare AG

13.19. Alere Inc.

13.20. Leica Biosystems

13.21. Agilient Technologies, Inc


"*Financials would be provided on a best efforts basis for private companies"

14. Appendix

14.1. Abbreviations

14.2. Sources

14.3. Research Methodology

14.4. Bibliography

14.5. Compilation of Expert Insights

14.6. Disclaimer

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 52500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 75-country survey from VPGMarketResearch.com provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market ...

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 47500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Europe diagnostic testing market, including Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, ...

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 35000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Asia-Pacific diagnostic testing market, including Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.